// App-Quantinova.ai

P2-08-08 : Circulating tumor cells count-based nomograms to predict survival of metastatic breast cancer patients: Results from the European pooled analysis

Researchers

Presenter

  • Bidard F-C

Principal Investigators

  • Fehm T

  • Gazzaniga P

  • Manso L

  • Zamarchi R

  • Fernandez de Lascoiti A

  • de Mattos-Arruda L

  • Ignatiadis M

  • van Laere SJ

  • Meier-Stiegen F

  • Sandri M-T

  • Vidal-Martinez J

  • Nole F

  • Politaki E

  • Gisbert-Criado R

  • Mavroudis D

  • Grisanti S

  • Generali D

  • Garcia-Saenz JA

  • Stebbing J

  • Caldas C

Medical Centers

  • Cancer Research UK, Cambridge Research Institute, Cambridge, United Kingdom

  • Sapienza University, Rome, Italy

  • Gustave Roussy, Villejuif, France

  • Hospital Doce de Octubre, Madrid, Spain

  • Azienda Istituti Ospitalieri di Cremona, Cremona, Italy

  • Hospital Arnau Vilanova, Valencia, Spain

  • University General Hospital of Heraklion, Heraklion, Greece

  • Vall d'Hebron Institute of Oncology, Barcelona, Spain

  • Heinrich Heine University Duesseldorf, Duesseldorf, Germany

  • Saarland University, Homburg, Germany.

  • University Institution Antwerp, Antwerp, Belgium

  • University of Ulm, Ulm, Germany

  • Spedali Civili, Brescia, Italy

  • Institute Jules Bordet, Brussels, Belgium

  • Hospital de Navarra, Pamplona, Spain

  • University Medical Center Hamburg Eppendorf, Hamburg, Germany

  • Institut Curie, Paris Cedex, France

  • International Drug Development Institute, Louvain-La-Neuve, Belgium

Locations

  • Italy

  • Greece

  • Spain

  • Germany

  • United Kingdom

  • France

  • Belgium

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

Biomarkers

  • Circulating tumor cells

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved